Source and evaluate external capabilities, technologies, and assets across all three pillars, drawing on drug discovery expertise and LSMD strategic needs.
Maintain a structured pipeline of external opportunities (asset acquisitions, research collaborations, discovery partnerships) with clear status tracking, strategic fit assessment, and next steps.
Relationship Building & Ecosystem Engagement
Build and sustain relationships across biotech, venture capital, academic, and CRO ecosystems to surface aligned opportunities.
Represent SM E&I at partnering events (JPM, BIO, BioEurope), venture showcases, and scientific conferences.
Due Diligence & Governance
Lead cross-functional scientific due diligence by coordinating input from medicinal chemistry, computational chemistry, automation, pharmacology, biophysics, and AI/ML.